Citations

Clear

4844 citation(s) found for "Yu, Eric".

Increased Incidence of Atrial Fibrillation in Patients with Rheumatoid Arthritis
Bacani, A. Kirstin , Crowson, Cynthia S. , Roger, Véronique L. , Gabriel, Sherine E., Matteson, Eric L.

Mayo Clinic

BioMed Research International | March 1, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-5

10.1155/2015/809514 | PMID 25815336 Get It

Objective. To investigate the incidence of atrial fibrillation (AF) among patients with rheumatoid arthritis (RA) compared to the general population.Methods. A population-based inception cohort of Olmsted County, Minnesota, residents with incident RA in 1980–2007 and a cohort of non-RA subjects from the same population base were assembled and followed until 12/31/2008. The occurrence of AF was ascertained by medical record review.Results. The study included 813 patients with RA and 813 non-RA subjects (mean age 55.9 (SD:15.7) years, 68% women in both cohorts). The prevalence of AF was similar in the RA and non-RA cohorts at RA incidence/index date (4% versus 3%;P=0.51). The cumulative incidence of AF during follow-up was higher among patients with RA compared to non-RA subjects (18.3% versus 16.3% at 20 years;P=0.048). This difference persisted after adjustment for age, sex, calendar year, smoking, and hypertension (hazard ratio: 1.46; 95% CI: 1.07, 2.00). There was no evidence of a differential impact of AF on mortality in patients with RA compared to non-RA subjects (hazard ratio 2.5 versus 2.8; interactionP=0.31).Conclusion. The incidence of AF is increased in patients with RA, even after adjustment for AF risk factors. AF related mortality risk did not differ between patients with and without RA.
Electromyographic findings in 37 patients with adult‐onset acid maltase deficiency
Kassardjian, Charles D. , Engel, Andrew G. , Sorenson, Eric J.

Mayo Clinic

Muscle & Nerve | February 23, 2015 | Volume: 51 | Issue: 5 | Pages: 759-761

10.1002/mus.24620 | PMID 25703805 Get It

ABSTRACTIntroduction: In acid maltase deficiency (AMD), electrical myotonia (EM) may be restricted to paraspinal muscles. A comprehensive description of the electromyographic (EMG) findings in AMD is lacking. The purpose of this study is to describe the EMG features in adult‐onset AMD, focusing on the distribution of EM. Methods: A retrospective chart review of AMD patients diagnosed at Mayo Clinic over age 18 years. Results: Thirty‐seven patients were included. Twenty‐eight (76%) had EM in at least 1 muscle, and EM was more common in paraspinal and proximal limb muscles. The tensor fasciae latae (TFL) was equally sensitive to the paraspinals for EM. Three of 4 patients had EM identified in the diaphragm. Conclusions: Approximately three‐quarters of adult‐onset AMD patients display EM on EMG. The paraspinal muscles and TFL are the most likely to demonstrate EM, and EM can be detected in the diaphragm of adult onset AMD patients. Muscle Nerve, 2015 Muscle Nerve 51:759–761, 2015
Immunodeficiency and Autoimmune Enterocolopathy Linked to NFAT5 Haploinsufficiency
Boland, Brigid S. , Widjaja, Christella E. , Banno, Asoka, Zhang, Bing , Kim, Stephanie H. , Stoven, Samantha, Jones, Marilyn C. , Su, Hao , Crowe, Sheila E., Bui, Jack D. , Ho, Samuel B. , Okugawa, Yoshinaga , Goel, Ajay , Marietta, Eric, Khosroheidari, Mahdieh, Jepsen, Kristen , Aramburu, J. , López‐Rodríguez, Cristina , Sandborn, William J. , Chang, John T. , Marietta, Eric V., Peterson, Michael Roy , Murray, Joseph A. , Harismendy, Olivier

Mayo Clinic

The Journal of Immunology | February 10, 2015 | Volume: 194 | Issue: 6 | Pages: 2551-2560

10.4049/jimmunol.1401463 | PMID 25667416 Get It

Abstract The link between autoimmune diseases and primary immunodeficiency syndromes has been increasingly appreciated. Immunologic evaluation of a young man with autoimmune enterocolopathy and unexplained infections revealed evidence of immunodeficiency, including IgG subclass deficiency, impaired Ag-induced lymphocyte proliferation, reduced cytokine production by CD8+ T lymphocytes, and decreased numbers of NK cells. Genetic evaluation identified haploinsufficiency of NFAT5, a transcription factor regulating immune cell function and cellular adaptation to hyperosmotic stress, as a possible cause of this syndrome. Inhibition or deletion of NFAT5 in normal human and murine cells recapitulated several of the immune deficits identified in the patient. These results provide evidence of a primary immunodeficiency disorder associated with organ-specific autoimmunity linked to NFAT5 deficiency.
New Options for Vascularized Bone Reconstruction in the Upper Extremity
Wagner, Eric R. , Nanos, George P., Moran, Steven L. , Wyles, Cody C. , Houdek, Matthew T. , Wagner, Eric R

Mayo Clinic

Seminars in Plastic Surgery | February 4, 2015 | Volume: 29 | Issue: 01 | Pages: 020-029

10.1055/s-0035-1544167 | PMID 25685100 Get It

Bioinformatics Strategies for Identifying Regions of Epigenetic Deregulation Associated with Aberrant Transcript Splicing and RNA-editing
Champion, Mia D., Hlady, Ryan A. , Yan, Huihuang , Evans, Jared M., Nie, Jeff, Nandakumar, Kannabiran, Davila, Jaime , Moore, Raymond M. , Nair, Asha, Zhu, Yuanxiao, Ördög, Tamás , Kocher, Jean-Pierre A., Jonasch, Eric, Tibes, Raoul , Lee, Jeong‐Heon , Bogenberger, James M. , O’Brien, Daniel J. , Kortüm, K. Martin , Zhang, Zhiguo , Joseph, Richard W. , Jonasch, Eric W. , Robertson, Keith D. , Ho, Thai H. , Davila, Jaime I

Mayo Clinic

Proceedings of the International Conference on Bioinformatics Models, Methods and Algorithms | February 2, 2015 | Volume: No volume available | Issue: No issue available | Pages: 163-170

10.5220/0005248001630170 Get It

Use of Clinical and Electrical Myotonia to Differentiate Childhood Myopathies
Ghosh, Partha S. , Sorenson, Eric J.

Mayo Clinic

Journal of Child Neurology | January 31, 2015 | Volume: 30 | Issue: 10 | Pages: 1300-1306

10.1177/0883073814559646 | PMID 25637645 Get It

We retrospectively reviewed 2030 childhood electromyograms performed over an 11-year period (2004-2014). Twenty children (1%) with myotonic discharges were identified and placed into 2 groups. Group A (electrical and clinical myotonia) comprised 9 children (8 with myotonia congenita and 1 with paramyotonia congenita); all of them had diffuse myotonic discharges without clinical weakness or elevated creatine kinase. Group B (electrical myotonia without clinical myotonia) comprised 11 children (4 with inflammatory myopathy; 3, congenital myopathy, 3, muscular dystrophy; and 1, congenital muscular dystrophy). Clinical weakness was demonstrated in all of them and elevated creatine kinase in 6; all had a myopathic electromyogram and scattered myotonic discharges. We conclude that myotonic discharges are a rare but characteristic spontaneous discharge identified during electrodiagnostic studies in children. The presence of electrical and clinical myotonia provides helpful clues to differentiate between various muscle disorders in children.
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
Taipaleenmäki, Hanna , Browne, Gillian , Akech, Jacqueline, Zustin, Jozef , Wijnen, André J. van , Stein, Janet L. , Hesse, Eric , Stein, Gary S., Lian, Jane B. , van Wijnen, Andre J, van Wijnen, Andre J

Mayo Clinic

Cancer Research | January 29, 2015 | Volume: 75 | Issue: 7 | Pages: 1433-1444

10.1158/0008-5472.can-14-1026 | PMID 25634212 Get It

Abstract Progression of breast cancer to metastatic bone disease is linked to deregulated expression of the transcription factor Runx2. Therefore, our goal was to evaluate the potential for clinical use of Runx2-targeting miRNAs to reduce tumor growth and bone metastatic burden. Expression analysis of a panel of miRNAs regulating Runx2 revealed a reciprocal relationship between the abundance of Runx2 protein and two miRNAs, miR-135 and miR-203. These miRNAs are highly expressed in normal breast epithelial cells where Runx2 is not detected, and absent in metastatic breast cancer cells and tissue biopsies that express Runx2. Reconstituting metastatic MDA-MB-231-luc cells with miR-135 and miR-203 reduced the abundance of Runx2 and expression of the metastasis-promoting Runx2 target genes IL11, MMP-13, and PTHrP. In addition, tumor cell viability was decreased and migration suppressed in vitro. Orthotopic implantation of MDA-MB-231-luc cells delivered with miR-135 or miR-203, followed by an intratumoral administration of the synthetic miRNAs, reduced the tumor growth and spontaneous metastasis to bone. Furthermore, intratibial injection of these miRNA-delivered cells impaired tumor growth in the bone environment and inhibited bone resorption. Importantly, reconstitution of Runx2 in MDA-MB-231-luc cells delivered with miR-135 and miR-203 reversed the inhibitory effect of the miRNAs on tumor growth and metastasis. Thus, we have identified that aberrant expression of Runx2 in aggressive tumor cells is related to the loss of specific Runx2-targeting miRNAs and that a clinically relevant replacement strategy by delivery of synthetic miRNAs is a candidate for a therapeutic approach to prevent metastatic bone disease by this route. Cancer Res; 75(7); 1433–44. ©2015 AACR.
Neural basis of nonanalytical reasoning expertise during clinical evaluation
Durning, Steven J. , Costanzo, Michelle E. , Artino, Anthony R. , Graner, John L. , Vleuten, Cees van der , Beckman, Thomas J. , Wittich, Christopher M. , Roy, Michael J. , Holmboe, Eric S. , Schuwirth, Lambert

Mayo Clinic

Brain and Behavior | January 29, 2015 | Volume: 5 | Issue: 3 | Pages: No page available

10.1002/brb3.309 | PMID 25798328 Get It

AbstractIntroductionUnderstanding clinical reasoning is essential for patient care and medical education. Dual‐processing theory suggests that nonanalytic reasoning is an essential aspect of expertise; however, assessing nonanalytic reasoning is challenging because it is believed to occur on the subconscious level. This assumption makes concurrent verbal protocols less reliable assessment tools.MethodsFunctional magnetic resonance imaging was used to explore the neural basis of nonanalytic reasoning in internal medicine interns (novices) and board‐certified staff internists (experts) while completing United States Medical Licensing Examination and American Board of Internal Medicine multiple‐choice questions.ResultsThe results demonstrated that novices and experts share a common neural network in addition to nonoverlapping neural resources. However, experts manifested greater neural processing efficiency in regions such as the prefrontal cortex during nonanalytical reasoning.ConclusionsThese findings reveal a multinetwork system that supports the dual‐process mode of expert clinical reasoning during medical evaluation.
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Savona, Michael R. , Malcovati, Luca , Komrokji, Rami S. , Tiu, Ramón V., Mughal, Tariq I. , Orazi, Attilio , Kiladjian, Jean‐Jacques , Padron, Eric , Solary, Éric , Tibes, Raoul , Itzykson, Raphaël , Cazzola, Mario , Maciejewski, Jaroslaw P. , Fenaux, Pierre , Garcia‐Manero, Guillermo , Gerds, Aaron T. , Sanz, Guillermo , Cervantes, Francisco , Germing, Ulrich, Cross, Nicholas C.P. , List, Alan F. , Mesa, Ruben, Mesa, Ruben A. , Niemeyer, Charlotte Marie , Germing, Ulrich , Gerds, Aaron T , Savona, Michael R , Komrokji, Rami S , Solary, Eric , Kiladjian, Jean-Jacques , Itzykson, Raphael , Malcovati, Luca , Cazzola, Mario , Sanz, Guillermo F , Orazi, Attilio , Cross, Nicholas C P

Mayo Clinic

Blood | January 26, 2015 | Volume: 125 | Issue: 12 | Pages: 1857-1865

10.1182/blood-2014-10-607341 | PMID 25624319 Get It

Abstract Myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) are hematologically diverse stem cell malignancies sharing phenotypic features of both myelodysplastic syndromes and myeloproliferative neoplasms. There are currently no standard treatment recommendations for most adult patients with MDS/MPN. To optimize efforts to improve the management and disease outcomes, it is essential to identify meaningful clinical and biologic end points and standardized response criteria for clinical trials. The dual dysplastic and proliferative features in these stem cell malignancies define their uniqueness and challenges. We propose response assessment guidelines to harmonize future clinical trials with the principal objective of establishing suitable treatment algorithms. An international panel comprising laboratory and clinical experts in MDS/MPN was established involving 3 independent academic MDS/MPN workshops (March 2013, December 2013, and June 2014). These recommendations are the result of this collaborative project sponsored by the MDS Foundation.